Denise Damek, MD
Neurology
Locations
Practice Locations
University of Colorado Cancer Center - Anschutz Medical Campus
720-848-0300
UCHealth Neurosciences Center - Anschutz Medical Campus
720-848-2080
UCHealth Brain and Spine Tumor Multidisciplinary Clinic - Anschutz Medical Campus
720-848-0300
Provider Expertise
Specialties
- Neurology ( 1998 )
- Neuro-Oncology
Conditions & Treatments
-
Cancers
-
Brain and Nervous System
Brain Tumors, Spine Diseases and Conditions
Education & Training
Medical Schools
MD, University of Texas Medical School at Houston (1992)
Undergraduate Schools
BS, University of Texas–Austin (TX) (1988)
Internships
College of Medicine, Mayo Clinic (Rochester) Program (1993)
Residency Program
College of Medicine, Mayo Clinic (Rochester) Program (1996)
Fellowships
Massachusetts General Hospital Program (1998)
Professional Memberships
American Academy of Neurology, Member
American Medical Association, Member
Society for Neuro-Oncology, Member
Research & Grants
Grants
A Randomized Phase 3 Open Label Study of Nivolumab versus Bevacizumab and a Safety Study of Nivolumab or Nivolumab in Combination with Ipilimumab in Adult Subjects with Recurrent Glioblastoma (2014)
Immunocellular Therapeutics Ltd. ICT-107-301. A phase III randomized double-blind, controlled study of ICT-107 with maintenance temozolomide (TMZ) in newly diagnosed glioblastoma following resection and concomitant TMZ chemoradiotherapy (2015)
Chart Review Study of Patients who Received IRESSA as Part of a Clinical Access Program (ICAP) in the United States (2015)
ABT-414 alone or ABT-414 plus temozolomide for recurrent glioblastoma: a randomized phase II study of the EORTC Brain Tumor Group (2016)
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined with Toca FC versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma (2016)
information for referring providers
Referral Contact Phone
(720) 848-0300
Referral Contact Fax
720-848-0360
Clinical Interests for Referring Providers
Neuro-oncology including: Diagnosis and Treatment of Primary and Metastic Tumors of Brain and Spinal Cord, Paraneoplastic Disorders and Other Neurologic Complications of Systemic Cancer, CNS Lymphoma, Radiation Necrosis involving Nervous System
